U.S. Professional Services Stock News

NYSE:NET
NYSE:NETIT

High Growth Companies With Strong Insider Confidence December 2025

As the U.S. stock market celebrates record highs with the S&P 500 and Dow Jones Industrial Average setting new closing records, investors are increasingly focusing on companies that demonstrate both growth potential and strong insider confidence. In this buoyant market environment, stocks with high insider ownership can be particularly appealing as they often signal management's belief in the company's future prospects, aligning their interests closely with those of shareholders.
NasdaqCM:PSIX
NasdaqCM:PSIXElectrical

Discovering Hidden Opportunities: 3 Undiscovered Gems in the US Market

As the U.S. market continues to reach new heights with the S&P 500 setting all-time records, investors are increasingly interested in exploring opportunities beyond the well-trodden paths of blue-chip stocks. In this dynamic environment, identifying small-cap stocks that offer unique growth potential can be particularly rewarding, especially when these companies demonstrate resilience and innovation amidst broader market trends.
NYSE:PLOW
NYSE:PLOWMachinery

Top Dividend Stocks To Consider In December 2025

As the U.S. stock market continues to reach new heights with the Dow Jones and S&P 500 setting fresh records, investors are increasingly seeking stable returns amidst a backdrop of rising gold and silver prices. In this dynamic environment, dividend stocks offer a compelling option for those looking to benefit from consistent income while participating in potential market gains.
NasdaqGM:RAPT
NasdaqGM:RAPTBiotechs

RAPT Therapeutics (RAPT) Is Up 8.0% After Index Additions And Trial Progress News Has The Bull Case Changed?

In December 2025, RAPT Therapeutics, Inc. was added to both the NASDAQ Biotechnology Index and the S&P Biotechnology Select Industry Index, following recent clinical and financing milestones. This index inclusion underscores how ozureprubart’s progress, combined with a US$250,000,000 equity raise extending cash runway into mid-2028, is sharpening investor focus on RAPT’s pipeline. We’ll now examine how ozureprubart’s Phase 2b food allergy trial clearance shapes RAPT Therapeutics’...
NYSE:NMM
NYSE:NMMShipping

How Investors Are Reacting To Navios Maritime Partners (NMM) Centralizing Power In A New Executive Office

Earlier this month, Navios Maritime Partners L.P. reshaped its leadership structure by promoting long-tenured insiders into newly created vice chair and president roles, while elevating key legal, risk, and finance executives to senior positions to support an integrated dry bulk, container, and tanker platform. This internal reshuffle concentrates decision-making around an executive office under Chairwoman Angeliki Frangou, signaling a focus on more coordinated corporate transactions, risk...